Autres langues Pharmigene, Inc.

Actions

Cours en clôture Taipei Exchange 30/09/2026			Varia. 5j.	Varia. 1 janv.
6,990 ^TWD	-1,41%		-0,85%	-29,39%

12/08	Pharmigene, Inc. publie ses résultats pour l'exercice clos le 30 juin 2026	CI
28/04	Pharmigene, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

12/08	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026
19/06	Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
28/04	Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
11/08/25	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
13/03/25	Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
12/08/24	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2024
30/04/24	Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
08/08/23	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
06/04/23	Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
12/08/22	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
12/04/22	Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
12/08/21	Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
25/04/21	Pharmigene,Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
09/09/20	S2 Genomics, Inc. Announces Distribution Partnerships With SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio